Search

Displaying results 9871 - 9880 of 10000 in total
  1. Drug

    Foslinanib

    go.drugbank.com/drugs/DB16172
    Investigational

    Foslinanib is under investigation in clinical trial NCT03600233 (Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors).

  2. Drug

    Elimusertib

    go.drugbank.com/drugs/DB19041
    Investigational

    Elimusertib is under investigation in clinical trial NCT05071209 (Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors).

    Categories: Heterocyclic Compounds, 1-RingSynonyms: 1,7-naphthyridine, 2-((3r)-3-methyl-4-morpholinyl)-4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-3-yl)-
  3. Drug

    Recaticimab

    go.drugbank.com/drugs/DB19302
    Investigational

    Recaticimab is under investigation in clinical trial NCT06467617 (Adebrelimab Plus Chemo and Recaticimab Perioperative Treatment for Resectable NSCLC).

    Synonyms: 艾心安, Immunoglobulin g1-kappa, anti-(homo sapienspcsk9 (proprotein convertase subtilisin/kexin type 9, neural apoptosis-regulated convertase 1, narc1, narc-1, proproteine convertase 9, pc9)), monoclonal antibody
  4. Drug

    Ethyl butyrate

    go.drugbank.com/drugs/DB15454
    Experimental

    Ethyl butyrate is under investigation in clinical trial NCT03202342 (fMRI of Hypothalamic Responses to Taste, Temperature and Glucose).

  5. Drug

    Nizaracianine

    go.drugbank.com/drugs/DB21517
    Investigational

    Nizaracianine is a small molecule drug. Nizaracianine is under investigation in clinical trial NCT05752149 (Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial). … Nizaracianine has a monoisotopic molecular weight of 942.43 Da.

  6. Drug

    Orticumab

    go.drugbank.com/drugs/DB16653
    Investigational

    Orticumab is under investigation in clinical trial NCT04776629 (A Proof-of-activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors).

  7. Drug

    Azoximer bromide

    go.drugbank.com/drugs/DB15689
    Investigational

    Azoximer bromide is under investigation in clinical trial NCT04381377 (Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19).

    Synonyms: Poly((1-(carboxymethyl)piperazin-1-ium-1,4-diyl bromide)ethylene-co-((piperazin-1,4-diyl 1-oxide)ethylene)Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    4'-Thio-fac

    go.drugbank.com/drugs/DB16071
    Investigational

    4'-Thio-fac is under investigation in clinical trial NCT02661542 (Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas).

    Synonyms: 4-Amino-1-[(2R,3S,4S,5R)-3-Fluoro-4-Hydroxy-5-(Hydroxymethyl)Tetrahydrothiophen-2-Yl] Pyrimidin-2(1H)-One, 4'-Thio-fac
  9. Drug

    HIV Integrase Inhibitor

    go.drugbank.com/drugs/DB16114
    Investigational

    HIV Integrase Inhibitor is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects).

    Categories: Heterocyclic Compounds, 1-Ring
  10. Drug

    VEGFR2-169

    go.drugbank.com/drugs/DB16152
    Investigational

    VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).